medigraphic.com
ISSN 1561-3119 (Electronic)

2021, Number 4

<< Back Next >>

Rev Cubana Pediatr 2021; 93 (4)

Multisystemic inflammatory syndrome in children associated with COVID-19

Pérez TE, Ríos UEP

Language: Spanish
References: 12
Page: 1-10
PDF size: 803.05 Kb.


ABSTRACT

Introduction: The condition of COVID-19 in children is mild or asymptomatic in most cases, but a small percentage has serious diseases that require admission to the pediatric intensive care unit, one of them is the multisystemic inflammatory syndrome in children associated with COVID-19, characterized by fever, high acute phase reactants and involvement of various organs.
Objective: To report two cases with multisystemic inflammatory syndrome in children associated with COVID-19, in Huancayo City - Peru.
Case report: Case 1: A 3-year-old male patient had 12-day illness period that began with upper respiratory symptoms, fever for three days, general discomfort and 4 days before admission, he showed with persistent fever, colicky abdominal pain associated with vomiting, also he had a purpuric rash on the lower limbs. As a background, his father tested positive for the PCR-RT test for COVID-19, 3 weeks before the child's admission. Case 2: A 10-year-old male patient, with a history of COVID-19 pneumonia, 15 days before admission, he had a 3-day illness period characterized by fever, fatigue and palpitations that exacerbated by physical activity.
Conclusions: The multisystemic inflammatory syndrome in children associated with COVID-19 is a new disease that requires multidisciplinary management in a pediatric intensive care unit.


REFERENCES

  1. Organización Mundial de la Salud (OMS). Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19 celebrada el 11 de marzo de 2020. Ginebra: OMS; 2020 [acceso 17/09/2020]. Disponible en: Disponible en: https://www.who.int/es/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020

  2. Jiang L, Tang K, Levin M, Irfan O, Morris S, Wilson K, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. The Lancet Infectious Diseases. 2020 [acceso 27/06/2021];20(11):e276-e288. doi: https://doi.org/10.1016/S1473-3099(20)30651-4

  3. Jones VG, Mills M, Suarez D. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020 [acceso 26/06/2021];10:537-40. Disponible en: Disponible en: https://hosppeds.aappublications.org/content/early/2020/05/26/hpeds.2020-0123

  4. Organización Mundial de la Salud. Multisystem inflammatory syndrome in children and adolescents with COVID-19. Geneva: WHO. 2020; [acceso 21/09/2020]. Disponible en: Disponible en: https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-andadolescents- with-covid-19

  5. Kaushik S, Aydin SI, Derespina KR, Bansal PB, Kowalsky S, Trachtman R, Gillen JK, Perez MM, Soshnick SH, Conway EE Jr, Bercow A, Seiden HS, Pass RH, Ushay HM, Ofori-Amanfo G, Medar SS. Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City. J Pediatr. 2020;224:24-9. doi: 10.1016/j.jpeds.2020.06.045.

  6. Taffarel P, Jorro F, Rodriguez A, Widner J, Meregalli C. Síndrome inflamatorio multisistémico en niños, relacionado con COVID-19: actualización a propósito de la presentación de 2 pacientes críticos. Arch Argent Pediatr 2021 [acceso 30/06/2021];119(1):e26-e35/e26. Disponible en: Disponible en: https://www.sap.org.ar/docs/publicaciones/archivosarg/2021/v119n1a18.pdf

  7. Godfred-Cato S, Bryant B, Leung J, Oster M, Conklin L, Abrams J, et al. COVID-19-Associated Multisystem Inflammatory Syndrome in Children -United States, March-July 2020. MMWR. 2020 [acceso 25/09/2020];69(32):1074-180. Disponible en: Disponible en: https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6932e2-H.pdf

  8. Ulloa-Gutiérrez R, Ivankovich-Escoto G, Yamazaki-Nakashimada M. Síndrome inflamatorio multisistémico asociado a COVID-19 en niños y adolescentes: un llamado al diagnóstico. Rev Chilena Infectol. 2020 [acceso 28/09/2020];37(3):199-201. Disponible en: Disponible en: https://scielo.conicyt.cl/pdf/rci/v37n3/0716-1018-rci-37-03-0199.pdf

  9. Lázaro A, Castro B, López L, Robaina G. Síndrome inflamatorio multisistémico en niños asociado a COVID 19. Rev Cubana Pediatr. 2020 [acceso 20/09/2020];92(Supl. especial):1-16. Disponible en: Disponible en: http://revpediatria.sld.cu/index.php/ped/article/view/1202

  10. Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M, et al. An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020 [acceso 17/09/2020];395:1771. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220177/pdf/main.pdf

  11. Asociación Española de Pediatría. Consenso nacional sobre diagnóstico, estabilización y tratamiento del Síndrome Inflamatorio Multisistémico Pediátrico vinculado a SARS-CoV-2 (SIM-PedS). Madrid 2020 [acceso 21/09/2020];1. Disponible en: Disponible en: https://www.aeped.es/sites/default/files/aep.sim-peds.v1.pdf

  12. Barrios Tascon A, Centeno Malfaz F, Rojo Sombrero H, et al. National consensus on the cardiological treatment and follow-up of Kawasaki disease. An Pediatr. 2018 [acceso 21/09/2020];89:188. Disponible en: Disponible en: https://www.analesdepediatria.org/en-pdf-S2341287918301406




2020     |     www.medigraphic.com